Citations

Mayo Clinic

Showing 10 of 108599 citations.

AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome
Hartley, Sigan L. , Handen, Benjamin L. , Tudorascu, Dana , Lee, Laisze, Cohen, Annie , Peven, Jamie C. , Klunk, William E. , Laymon, Charles M. , Luo, Weiquan, Ances, Beau M. , Preboske, Gregory M., Christian, Bradley T. , Cohen, Ann D. , Preboske, Gregory, Ances, Beau M , Schworer, Emily K. , Zammit, Matthew D. , Minhas, Davneet Singh , Zaman, Shahid H.

Alzheimer's & Dementia | August 29, 2023 | Volume: 20 | Issue: 1 | Pages: 366-375

10.1002/alz.13446 | PMID 37641428 Get It

AbstractINTRODUCTIONDown syndrome (DS) is a genetic cause of early‐onset Alzheimer's disease (AD). The National Institute on Aging–Alzheimer's Association AT(N) Research Framework is a staging model for AD biomarkers but has not been assessed in DS.METHODData are from the Alzheimer's Biomarker Consortium–Down Syndrome. Positron emission tomography (PET) amyloid beta (Aβ; 15 mCi of [11C]Pittsburgh compound B) and tau (10 mCi of [18F]AV‐1451) were used to classify amyloid (A) –/+ and tau (T) +/–. Hippocampal volume classified neurodegeneration (N) –/+. The modified Cued Recall Test assessed episodic memory.RESULTSAnalyses included 162 adults with DS (aged M = 38.84 years, standard deviation = 8.41). Overall, 69.8% of participants were classified as A–/T–/(N)–, 11.1% were A+/T–/(N)–, 5.6% were A+/T+/(N)–, and 9.3% were A+/T+/(N)+. Participants deemed cognitively stable were most likely to be A–T–(N)– and A+T–(N)–. Tau PET (T+) most closely aligning with memory impairment and AD clinical status.DISCUSSIONFindings add to understanding of AT(N) biomarker profiles in DS.Highlights Overall, 69.8% of adults with Down syndrome (DS) aged 25 to 61 years were classified as amyloid (A)–/tau (T)–/neurodegeneration (N)–, 11.1% were A+/T–/(N)–, 5.6% were A+/T+/(N)–, and 9.3% were A+/T+/(N)+. The AT(N) profiles were associated with clinical Alzheimer's disease (AD) status and with memory performance, with the presence of T+ aligned with AD clinical symptomology. Findings inform models for predicting the transition to the prodromal stage of AD in DS.
Medulläres Schilddrüsenkarzinom
Köhler, Viktoria, Spitzweg, Christine , Kroiß, Matthias

Angewandte Nuklearmedizin | August 28, 2023 | Volume: 46 | Issue: 03 | Pages: 241-246

10.1055/a-2030-6731 Get It

Zusammenfassung Diagnose und Prognose Calcitonin ist ein sensitiver und spezifischer Tumormarker zur Früherkennung und Verlaufskontrolle des MTC. Daneben kommt dem Ultraschall der Schilddrüse eine entscheidende Rolle zu. Rolle des RET-Proto-Onkogens Das medulläre Schilddrüsenkarzinom (MTC) nimmt seinen Ursprung aus den parafollikulären calcitoninproduzierenden C-Zellen. Es macht nur ca. 3–8% aller Schilddrüsenkarzinome aus. Aktivierende Mutationen im RET (rearranged during transfection)-Gen liegen bei etwa 25% der Patienten in der Keimbahn vor, werden aber auch beim sporadischen MTC als somatische Mutationen in ca. 60% der Fälle beobachtet. Bei metastasierter Erkrankung findet sich in 90% eine RET-Mutation. RET-Mutationen gelten als Treibermutationen und schließen weitere Treibermutationen weitestgehend aus. Seltener sind somatische Mutationen der RAS-Gene. Chirurgische Therapie Die chirurgische Resektion ist bis heute der einzige kurative Therapieansatz. Entscheidend für eine frühzeitige Diagnosestellung ist die Bestimmung des Serum-Calcitonins bei Nachweis von Schilddrüsenknoten. Die chirurgische Therapie steht auch bei der Behandlung lokoregionärer Rezidive oder lokal angehbarer Metastasen im Zentrum. Systemtherapie Bei irresektabel fortgeschrittener und progredienter Erkrankung mit signifikanter Tumorlast kann eine systemische Therapie erforderlich werden. Neuerdings ist die Kenntnis einer RET-Mutation im Tumorgewebe therapeutisch relevant, da mit dem selektiven RET-Inhibitor Selpercatinib eine neue, effektive und gut verträgliche Systemtherapien zur Verfügung steht. Dieser ist inzwischen wie bisher nur die Multityrosinkinaseinhibitoren Cabozantinib und Vandetanib als Erstlinientherapie des fortgeschrittenen MTC zugelassen. Vandetanib darf ebenfalls nur noch bei Patienten mit RET-Mutation angewendet werden.
Selective upper trunk posterior division fascicular nerve transfer for proximal spinal accessory neuropathy: illustrative case
Wu, Kitty Y. , Spinner, Robert J.

Journal of Neurosurgery: Case Lessons | August 28, 2023 | Volume: 6 | Issue: 9 | Pages: No page available

10.3171/case23348 | PMID 37728327 Get It

BACKGROUND Spinal accessory nerve palsy can lead to severe shoulder pain and weakness, lateral scapular winging, and limitations in overhead activity. It most often occurs because of iatrogenic injury from procedures within the posterior triangle of the neck. OBSERVATIONS The authors present the case of a 39-year-old male with symptoms of right shoulder weakness and neck pain after a total thyroidectomy and right neck dissection. With ultrasound findings of a neuroma-in-continuity but no clinical or electromyographic signs of reinnervation at 6 months, surgical intervention was indicated. Operative exploration confirmed a very proximal injury and nonconducting neuroma-in-continuity of the spinal accessory nerve. A selective distal nerve transfer from the posterior division of the upper trunk was performed. At the 2.5-year follow-up, the patient demonstrated excellent recovery of full active shoulder abduction and forward flexion, return to full-time employment, and mild residual scapular winging. LESSONS Distal nerve transfers should be considered in cases of late presentation when primary repair is not possible or long interpositional grafts are required. Selective fascicular transfer from the posterior division of the upper trunk provides the advantages of a single incision, short reinnervation time, and synergistic donor function to facilitate motor reeducation.
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes
Raghinaru, Dan, Kudva, Yogish C. , Pandit, Keta, Blevins, Thomas , Casaubon, Luis, Desjardins, Donna, Levister, Camilla, O’Malley, Grenye , Reid, Corey, Lum, John W. , Kollman, Craig , Lum, John , Levy, Carol J. , Beck, Roy W.

Clinical Diabetes | August 28, 2023 | Volume: 42 | Issue: 1 | Pages: 116-124

10.2337/cd23-0025 | PMID 38230336 Get It

The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70–180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL.
Analysis of Accumulated Workloads and Performance Testing Across a Collegiate Women's Lacrosse Season
Fields, Jennifer B. , Kuhlman, Nicholas M., Dulak-sigler, Corey, Jones, Margaret T. , Jones, Margaret T , Jagim, Andrew R.

Journal of Strength & Conditioning Research | August 28, 2023 | Volume: 37 | Issue: 11 | Pages: 2213-2221

10.1519/jsc.0000000000004551 | PMID 37639657 Get It

Abstract Fields, JB, Kuhlman, NM, Jagim, AR, Dulak-Sigler, C, and Jones, MT. Analysis of accumulated workloads and performance testing across a collegiate women's lacrosse season. J Strength Cond Res 37(11): 2213–2221, 2023—Monitoring accumulated workloads, acute:chronic workload ratios (ACWR), and training monotony (TM) are practical methods for monitoring athlete physical stress. Performance testing provides useful information about the changing nature of physical abilities. Therefore, the purpose was to examine differences in accumulated workloads based on session type, explore seasonal trends in ACWR and TM, and assess changes in performance assessments in collegiate women's lacrosse athletes. Athletes, who were identified as starters ( n = 12), wore positional monitoring technology during training sessions ( n = 61) and games ( n = 17) and completed preseason and postseason assessments of speed, agility, power (jump tests), strength, aerobic capacity, and body composition. Separate 1-way analyses of variance were used to determine differences in accumulated workloads for session type and differences in performance assessments from preseason to postseason ( p < 0.05). When compared with games, practice sessions elicited greater ( p < 0.001) accumulated total distance, player load, repeated high-intensity efforts, accelerations, change of direction, explosive efforts, high-speed efforts ( p = 0.002), and high-speed distance ( p = 0.002). Throughout the season, ACWR and TM ranged from 0.16 to 1.40 AU and 0.68–1.69 AU, respectively. The 40-yd sprint ( p < 0.001) and pro-agility ( p < 0.001) improved from preseason to postseason, whereas no changes in aerobic capacity, lower-body power, or strength were observed ( p > 0.05). The monitoring of accumulated loads, ACWR and TM, and performance tests revealed novel information about the seasonal demands of collegiate women's lacrosse. Women lacrosse players are able to improve speed and agility throughout the season, while maintaining strength, power, and endurance, with minimal reductions in fat-free mass.
Athlete External Load Measures Across a Competitive Season in High School Basketball
Askow, Andrew T. , Fields, Jennifer B. , Beaudoin, Remington G., Sanchez, Giuliano M., Weeks, Jeremy, Oliver, Jonathan M. , Jones, Margaret T. , Jones, Margaret T , Askow, Andrew T , Jennings, Will , Jagim, Andrew R. , Sanchez, Giuliano M.

Journal of Strength & Conditioning Research | August 28, 2023 | Volume: 37 | Issue: 11 | Pages: 2206-2212

10.1519/jsc.0000000000004552 | PMID 37639668 Get It

Abstract Askow, AT, Jennings, W, Jagim, AR, Fields, JB, Beaudoin, RG, Sanchez, GM, Weeks, JE, Oliver, JM, and Jones, MT. Athlete external load measures across a competitive season in high school basketball. J Strength Cond Res 37(11): 2206–2212, 2023—The purpose of this retrospective analysis was to quantify in-season external load and to determine if relationships existed between load metrics and basketball performance. Eleven male high school varsity basketball athletes (n = 11; mass 80.5 ± 9.6 kg, height 190.2 ± 9.4 cm, age 17.6 ± 0.7 years) were monitored across a season. PlayerLoad (PL), PL per minute (PL·min −1 ), total jumps, and explosive movements (EMs) were quantified using a commercially available local positioning unit. Basketball-specific performance metrics, including points scored, points allowed, point differentials, and shooting percentages for each quarter and game, were compiled. Data were analyzed using repeated-measure analysis of variance to evaluate differences in load by starting status, session type, game outcome, and game type. Pearson's correlation coefficients were used to assess relationships between load metrics and basketball performance. Statistical significance was set at p < 0.05. The mean values across 23 games for PL, PL·min −1 , total jumps, and EMs were 457 ± 104 AU, 10.9 ± 1.6 AU, 42.6 ± 9.6, and 46.7 ± 7.2, respectively. Relationships were observed ( p < 0.05) between PL and points scored ( r = 0.38) and free throw percentage ( r = 0.21). Further relationships were observed between PL·min −1 and free throw shooting percentage ( r = −0.27), and between points scored and total jumps ( r = 0.28), and EMs ( r = 0.26). Notable differences in game demands were observed for playing status. Meaningful differences in measures of external load were observed between each quarter of play, with the highest measures evident in quarters 1 and 3. Guards and forwards experienced minimal differences in external load during gameplay, and game outcome did not result in differences. Higher point totals corresponded with higher PL, total jumps, and EM.
Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma
Paiva, Bruno , Núñez‐Córdoba, Jorge M. , Rodríguez‐Otero, Paula , Munshi, Nikhil C. , Durie, Brian G.M. , Miguel, Jesús F. San , Rodriguez-Otero, Paula , San-Miguel, Jesus , Paiva, Bruno , Zherniakova, Anastasiia , Shi, Qian

Blood Advances | August 28, 2023 | Volume: 8 | Issue: 1 | Pages: 219-223

10.1182/bloodadvances.2023010821 | PMID 37639322 Get It

Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis
Abdel‐Razek, Omar , Santo, Pietro Di , Jung, Richard G. , Parlow, Simon , Motazedian, Pouya , Visintini, Sarah , Labinaz, Marino , Mathew, Rebecca , Hibbert, Benjamin , Hibbert, Benjamin , Prosperi‐Porta, Graeme , Marbach, Jeffrey A. , Ramirez, F. Daniel , Simard, Trevor

Critical Care Explorations | August 28, 2023 | Volume: 5 | Issue: 9 | Pages: e0962

10.1097/cce.0000000000000962 | PMID 37649849 Get It

OBJECTIVES: Inotropic support is commonly used in patients with cardiogenic shock (CS). High-quality data guiding the use of dobutamine or milrinone among this patient population is limited. We compared the efficacy and safety of these two inotropes among patients with low cardiac output states (LCOS) or CS. DATA SOURCES: MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were searched up to February 1, 2023, using key terms and index headings related to LCOS or CS and inotropes. DATA EXTRACTION: Two independent reviewers included studies that compared dobutamine to milrinone on all-cause in-hospital mortality, length of ICU stay, length of hospital stay, and significant arrhythmias in hospitalized patients. DATA SYNTHESIS: A total of eleven studies with 21,084 patients were included in the meta-analysis. Only two randomized controlled trials were identified. The primary outcome, all-cause mortality, favored milrinone in observational studies only (odds ratio [OR] 1.19 (95% CI, 1.02–1.39; p = 0.02). In-hospital length of stay (LOS) was reduced with dobutamine in observational studies only (mean difference –1.85 d; 95% CI –3.62 to –0.09; p = 0.04). There was no difference in the prevalence of significant arrhythmias or in ICU LOS. CONCLUSIONS: Only limited data exists supporting the use of one inotropic agent over another exists. Dobutamine may be associated with a shorter hospital LOS; however, there is also a potential for increased all-cause mortality. Larger randomized studies sufficiently powered to detect a difference in these outcomes are required to confirm these findings.
Development of an Electronic Health Record–Based Clinical Decision Support Tool for Patients With Lynch Syndrome
Lau‐Min, Kelsey S. , Bleznuck, Joseph, Wollack, Colin, McKenna, Danielle , Long, Jessica M. , Hubert, Anna P. , Johnson, Mariah, Rochester, Shavon E., Constantino, Gillain , Dudzik, Christina , Doucette, Abigail , Wangensteen, Kirk J. , Landgraf, Jeffrey, Chen, Jessica , Nathanson, Katherine L. , McKenna, Danielle B , Wangensteen, Kirk J , Domchek, Susan M , Nathanson, Katherine L , Katona, Bryson W , Domchek, Susan M.

JCO Clinical Cancer Informatics | August 28, 2023 | Volume: No volume available | Issue: 7 | Pages: No page available

10.1200/cci.23.00024 | PMID 37639653 Get It

PURPOSE To develop an electronic health record (EHR)–based clinical decision support (CDS) tool to promote guideline-recommended cancer risk management among patients with Lynch syndrome (LS), an inherited cancer syndrome that confers an increased risk of colorectal and other cancer types. MATERIALS AND METHODS We conducted a cross-sectional study to determine the baseline prevalence and predictors of guideline-recommended colonic surveillance and annual genetics program visits among patients with LS. Multivariable log-binomial regressions estimated prevalence ratios (PRs) of cancer risk management adherence by baseline sociodemographic and clinical characteristics. These analyses provided rationale for the development of an EHR-based CDS tool to support patients and clinicians with LS-related endoscopic surveillance and annual genetics program visits. The CDS leverages an EHR platform linking discrete genetic data to LS Genomic Indicators, in turn driving downstream clinician- and patient-facing CDS. RESULTS Among 323 patients with LS, cross-sectional adherence to colonic surveillance and annual genetics program visits was 69.3% and 55.4%, respectively. Patients with recent electronic patient portal use were more likely to be adherent to colonic surveillance (PR, 1.67; 95% CI, 1.11 to 2.52). Patients more recently diagnosed with LS were more likely to be adherent to annual genetics program visits (PR, 0.58; 95% CI, 0.44 to 0.76 for 2-4 years; PR, 0.62; 95% CI, 0.51 to 0.75 for ≥4 compared with <2 years). Our EHR-based CDS tool is now active for 421 patients with LS throughout our health system. CONCLUSION We have successfully developed an EHR-based CDS tool to promote guideline-recommended cancer risk management among patients with LS.
Arterial Health After Preeclampsia: Role of Chronic Hypertension in the Early Vascular Aging (EVA) Study
Paquin, Amélie , Coutinho, Thais , Coutinho, Thais D. , Werlang, Ana

American Journal of Hypertension | August 28, 2023 | Volume: 37 | Issue: 1 | Pages: 24-32

10.1093/ajh/hpad079 | PMID 37638873 Get It

Abstract BACKGROUND Preeclampsia (PE) is associated with increased cardiovascular risk. Recent data have shown worse left ventricular remodeling and diastolic function in women with PE and persistent hypertension (HTN). We performed a comprehensive arterial hemodynamic assessment to evaluate the contribution of persistent HTN on arterial health after PE. METHODS We recruited 40 women with PE history and 40 age-matched controls (6 months to 6 years postpartum). We evaluated arterial hemodynamics with validated techniques combining applanation tonometry and transthoracic echocardiography, comparing three groups: previous PE with persistent HTN (PE-HTN), previous PE with normalized blood pressure (PE-noHTN) and controls, using multivariable linear regression adjusted for age, body surface area, heart rate, diabetes, smoking history, creatinine, and gravidity. RESULTS Eight (20%) of the post-PE women had persistent HTN. Mean age was 35.8 ± 3.9 years, median number of pregnancies was 2 (range 1–7), and time since last pregnancy 2.1 (range 0.5–5.7) years (not different between groups, P &gt; 0.05). Compared to controls and to PE-noHTN, PE-HTN had higher aortic stiffness, wave reflections, pulsatile, and steady arterial load (P &lt; 0.05 for each). Among PE-noHTN, aortic stiffness, wave reflections and steady arterial load were worse than controls (P &lt; 0.05 for each), with smaller effect sizes. CONCLUSIONS This is the most comprehensive assessment of arterial hemodynamics and first to demonstrate the contribution of persistent HTN on worse arterial health following PE. Since measures of arterial health are associated with cardiovascular events in the population, the combination of previous PE and chronic HTN may represent a higher risk subgroup who could benefit from targeted prevention strategies.